Iran vs Solomon Islands: The number of people with susceptibility test result for rifampicin
Iran
46.76
in 2021
Solomon Islands
45.52
in 2021
Iran rank
116th
Solomon Islands rank
118th
The number of people with susceptibility test result for rifampicin over time
- Iran
- Solomon Islands
How they compare
Iran currently reports 46.76 against 45.52 in Solomon Islands, a difference of 1.24.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Iran ahead.
Iran ranks 116th and Solomon Islands ranks 118th of 146 countries.
Across the 2 decades both report, Iran averaged higher in 1 and Solomon Islands in 1.
Head to head by decade
| Decade | Iran | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64 | 0 | 64 | Iran |
| 2020s | 45.93 | 55.88 | 9.96 | Solomon Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Iran or Solomon Islands?
- Iran, at 46.76 against 45.52 in Solomon Islands as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Iran and Solomon Islands?
- 1.24, with Iran ahead.
- How many years of comparable data are there for Iran and Solomon Islands?
- 5 years are reported by both, from 2017 to 2021.
- How do Iran and Solomon Islands rank globally for the number of people with susceptibility test result for rifampicin?
- Iran ranks 116th and Solomon Islands ranks 118th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.